2024
Unforeseen and Immediate: A Case of a Post-Watchman Device-Related Thrombus
Sethi S, Stolear A, Dulgher M, Nwokeocha N, Mejia V, Shkolnik E. Unforeseen and Immediate: A Case of a Post-Watchman Device-Related Thrombus. Cureus 2024, 16: e63442. PMID: 39077225, PMCID: PMC11284824, DOI: 10.7759/cureus.63442.Peer-Reviewed Original ResearchDevice-related thrombusLeft atrial appendageOral anticoagulantsLAA occlusionLong-term oral anticoagulationAssociated with increased morbidityLeft atrial appendage occlusionHeparin dripPeriprocedural managementPrompt diagnosisThrombus resolutionSafety profileRare caseWatchman deviceArterial thromboembolismAtrial fibrillationAtrial appendageLeft atriumPersistent AFibAtrial sideRisk factorsBlood clot formationThrombusPatientsTherapeutic interventions
2023
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19
Gulati S, Hsu C, Shah S, Shah P, Zon R, Alsamarai S, Awosika J, El-Bakouny Z, Bashir B, Beeghly A, Berg S, de-la-Rosa-Martinez D, Doroshow D, Egan P, Fein J, Flora D, Friese C, Fromowitz A, Griffiths E, Hwang C, Jani C, Joshi M, Khan H, Klein E, Heater N, Koshkin V, Kwon D, Labaki C, Latif T, McKay R, Nagaraj G, Nakasone E, Nonato T, Polimera H, Puc M, Razavi P, Ruiz-Garcia E, Saliby R, Shastri A, Singh S, Tagalakis V, Vilar-Compte D, Weissmann L, Wilkins C, Wise-Draper T, Wotman M, Yoon J, Mishra S, Grivas P, Shyr Y, Warner J, Connors J, Shah D, Rosovsky R, Gandhi R, Gartrell B, Goel S, Halmos B, Makower D, O' Sullivan D, Ohri N, Sica R, Verma A, Butt O, Fiala M, Henderson J, Monahan R, Stockerl-Goldstein K, Zhou A, Bitran J, Hallmeyer S, Mundt D, Pandravada S, Papaioannou P, Patel M, Streckfuss M, Tadesse E, Thompson M, Lammers P, Loree J, Yu I, Bindal P, Lam B, Peters M, Piper-Vallillo A, Arvanitis P, Egan P, Farmakiotis D, Olszewski A, Vieira K, Angevine A, Bar M, Del Prete S, Fiebach M, Gulati A, Hatton E, Houston K, Rose S, Steve Lo K, Stratton J, Weinstein P, Garcia J, Routy B, Hoyo-Ulloa I, Gupta S, Nizam A, Pennell N, Sharifi N, Hoppenot C, Li A, Bitterman D, Choueiri T, Connors J, Demetri G, El Zarif T, Florez N, Freeman D, Giordano A, Morgans A, Nohria A, Tolaney S, Van Allen E, Xu W, Halabi S, Zhang T, Dzimitrowicz H, Leighton J, Graber J, Hawley J, Loggers E, Lyman G, Lynch R, Portuguese A, Schweizer M, Su C, Tachiki L, Vinayak S, Wagner M, Yeh A, Dansoa Y, Gatson N, Makary M, Manikowski J, Vadakara J, Yossef K, Beckerman J, Goyal S, Messing I, Provenzano D, Rao Y, Rosenstein L, Steffes D, Clement J, Cosin J, Daher A, Dailey M, Elias R, Eton O, Hosmer W, Hsu E, Jayaraj A, Mather J, Menendez A, Nadkarni R, Serrano O, Yu P, Gadgeel S, Tejwani S, Accordino M, Bhutani D, Bodin B, Hershman D, Ingham M, Khan S, Masson C, Schwartz G, Alexander M, Matar S, Reuben D, Bernicker E, Deeken J, Jeffords K, Shafer D, Cárdenas-Delgado A, Cuervo Campos R, De-la-Rosa-Martinez D, Ramirez A, Valdez-Reyes N, Gill D, Lewis M, Low C, Rhodes T, Jones M, Mansoor A, Mashru S, Werner M, Cohen A, Hayes-Lattin B, McWeeney S, Nemecek E, Williamson S, Lewis G, Smith S, Akhtari M, Castillo D, Cortez K, Park K, Reeves M, Berg S, O'Connor T, Altman J, Gurley M, Mulcahy M, Wehbe F, Durbin E, Kulkarni A, Nelson H, Ramesh V, Sachs Z, Wilson G, Bardia A, Boland G, Gainor J, Peppercorn J, Reynolds K, Zubiri L, Campian J, Smith K, Bekaii-Saab T, Desai A, Halfdanarson T, Joyner M, Riaz I, Senefeld J, Williams C, Bonnen M, Mahadevan D, Ramirez A, Salazar M, Wang C, Mesa R, Bouganim N, Elkrief A, Moria F, Panasci J, Papenburg J, Vinh D, Nanchal R, Singh H, Bahadur N, Bao T, Nambiar P, O’Cearbhaill R, Papadopoulos E, Philip J, Riely G, Robson M, Rosenberg J, Schoenfeld A, Tamimi R, Cerrone K, Dill J, Faller B, Ajmera A, Brouha S, Choi S, Hsiao A, Reid E, Bhatt P, Mariano M, Thomson C, Glace M, Knoble J, Rink C, Zacks R, Blau S, Brown C, Namburi S, Pomerantz L, Rovito M, Advani P, Cronin T, Fleissner B, Goel S, Gopalakrishnan D, Hernandez-Ilizaliturri F, Jain P, Kariapper A, Levine E, Moffitt M, O'Connor T, Puzanov I, Smith L, Wicher C, Zsiros E, Jabbour S, Misdary C, Shah M, Batist G, Cook E, Esfahani K, Ferrario C, Lau S, Ma K, Miller W, Rudski L, Santos Dutra M, Wilchesky M, Mahmood S, McNair C, Mico V, Rivera A, Dixon B, Heilman H, Logan B, Mandapakala C, Cabebe E, Glover M, Jha A, Khaki A, Nagpal S, Schapira L, Shah S, Wu J, Subbiah S, Whaley D, Lopes G, de Cardenas K, Russell K, Stith B, Taylor S, Klamerus J, Revankar S, Addison D, Chen J, Gatti-Mays M, Jhawar S, Palmer J, Pillainayagam C, Stover D, Wall S, Williams N, Abbasi S, Annis S, Greenland S, Jones R, Kasi A, Rock C, Wulff-Burchfield E, Smits M, Weiss M, Chism D, Owenby S, Ang C, Galsky M, Metzger M, Berenberg J, Uyehara C, Fazio A, Huber K, Lashley L, Sueyoshi M, Patel K, Riess J, Borno H, Small E, Zhang S, Andermann T, Jensen C, Rubinstein S, Wood W, Ahmad S, Grover P, Jandarov R, Kharofa J, Li N, Marcum M, Sohal D, Zamulko O, Abidi M, Balmaceda N, Bowles D, Geiger C, Markham M, Russ A, Saker H, Acoba J, Choi H, Rho Y, Feldman L, Gantt G, Hoskins K, Khan M, Liu L, Nguyen R, Pasquinelli M, Schwartz C, Venepalli N, Vikas P, Zakharia Y, Boldt A, Fecher L, Su C, Bijjula R, Mavromatis B, Seletyn M, Wood B, Zaman Q, Kaklamani V, Brown A, Charles L, Cheng A, Crispens M, Croessmann S, Davis E, Ding T, Duda S, Enriquez K, French B, Gillaspie E, Hausrath D, Hennessy C, Johnson D, Lewis J, Li X, Prescott L, Reid S, Saif S, Shyr Y, Slosky D, Solorzano C, Sun T, Wang L, Yang Y, Aboulafia D, Carducci T, Goldsmith K, Van Loon S, Topaloglu U, Moore J, Cabalona W, Shisler E, Barrow McCollough B, Peddi P, Rosen L, Bilen M, Castellano C, Ravindranathan D, Hafez N, Herbst R, LoRusso P, Lustberg M, Masters T, Stratton C, Painter C, Peters S. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19. JAMA Oncology 2023, 9: 1390-1400. PMID: 37589970, PMCID: PMC10436185, DOI: 10.1001/jamaoncol.2023.2934.Peer-Reviewed Original ResearchConceptsThromboembolic eventsVenous thromboembolismArterial thromboembolismRelative riskTreatment of interestCohort studyMAIN OUTCOMECOVID-19Laboratory-confirmed SARS-CoV-2 infectionHigher intensive care unit admissionMultivariable log-binomial regression analysisRegistry-based retrospective cohort studyHistory of VTEIncidence of VTEIntensive care unit admissionLog-binomial regression analysisSARS-CoV-2 infectionCare unit admissionPoor performance statusRetrospective cohort studySystemic anticancer therapyAnticancer therapyType of therapyCOVID-19 diagnosisActive cancer
2021
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry
Giannis D, Consortium O, Allen S, Tsang J, Flint S, Pinhasov T, Williams S, Tan G, Thakur R, Leung C, Snyder M, Bhatia C, Garrett D, Cotte C, Isaacs S, Gugerty E, Davidson A, Marder G, Schnitzer A, Goldberg B, McGinn T, Davidson K, Barish M, Qiu M, Zhang M, Goldin M, Matsagkas M, Arnaoutoglou E, Spyropoulos A. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood 2021, 137: 2838-2847. PMID: 33824972, PMCID: PMC8032474, DOI: 10.1182/blood.2020010529.Peer-Reviewed Original ResearchConceptsIntensive care unitArterial thromboembolismVenous thromboembolismMajor bleedingPostdischarge anticoagulationPostdischarge thromboprophylaxisVTE scorePrimary outcomeAdvanced ageCoronavirus disease 2019 (COVID-19) inpatientsPostdischarge venous thromboembolismPrincipal safety outcomePrior venous thromboembolismCardiovascular risk factorsChronic kidney diseasePeripheral arterial diseasePrimary outcome rateCarotid occlusive diseaseCoronary artery diseaseCOVID-19 hospitalizationCOVID-19Electronic health recordsThromboembolic outcomesVTE ratesCause mortality
2012
Arterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis
Proverbs-Singh T, Chiu S, Liu Z, Seng S, Sonpavde G, Choueiri T, Tsao C, Yu M, Hahn N, Oh W, Galsky M. Arterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis. Journal Of The National Cancer Institute 2012, 104: 1837-1840. PMID: 23093559, DOI: 10.1093/jnci/djs435.Peer-Reviewed Original ResearchConceptsArterial thromboembolic eventsIncreased risk of arterial thromboembolic eventsIncidence of arterial thromboembolic eventsNon-cisplatin-based chemotherapyPatients treated with cisplatin-based chemotherapyRisk of arterial thromboembolic eventsMeta-analysis of randomized controlled trialsCisplatin-based chemotherapyMeta-analysisConfidence intervalsRandom-effects modelCisplatin-basedRandomized Controlled TrialsIII trialsThromboembolic eventsRetrospective studySolid tumorsCase reportArterial thromboembolismCancer patientsIncreased riskControlled TrialsIncidence ratePatientsSystemic review
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply